Cargando…

Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants

AIMS: Atrial fibrillation (AF)/atrial flutter is common during cardiac amyloidosis (CA). Electrical cardioversion (EC) is a strategy to restore sinus rhythm (SR). However, left atrial thrombus (LAT) represents a contraindication for EC. CA patients with AF/atrial flutter have a high prevalence of LA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Touboul, Olivier, Algalarrondo, Vincent, Oghina, Silvia, Elbaz, Nathalie, Rouffiac, Segolene, Hamon, David, Extramiana, Fabrice, Gandjbakhch, Estelle, D'Humieres, Thomas, Marijon, Eloi, Dhanjal, Tarvinder S., Teiger, Emmanuel, Damy, Thibaud, Lellouche, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715864/ https://www.ncbi.nlm.nih.gov/pubmed/35903879 http://dx.doi.org/10.1002/ehf2.14082

Ejemplares similares

Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real‐world experience
por: Moulin, Thibaut, et al.
Publicado: (2022)

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
por: Broussier, Amaury, et al.
Publicado: (2021)

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
por: Bézard, Mélanie, et al.
Publicado: (2021)

The challenge of optimising ablation lesions in catheter ablation of ventricular tachycardia
por: Proietti, Riccardo, et al.
Publicado: (2020)

Severe Heart Failure Associated With Tachycardia-Induced Cardiomyopathy Due to Incessant Atrioventricular Re-Entrant Tachycardia
por: Moulin, Thibaut, et al.
Publicado: (2021)

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2020)

Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry
por: Lellouche, Nicolas, et al.
Publicado: (2021)

Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation
por: Oghina, Silvia, et al.
Publicado: (2021)

Prevalence and determinants of iron deficiency in cardiac amyloidosis
por: Jobbé‐Duval, Antoine, et al.
Publicado: (2022)

Impact of peri-procedural management of direct oral anticoagulants on pocket haematoma after cardiac electronic device implantation: the StimAOD multicentre prospective study
por: Martin, Anne-Céline, et al.
Publicado: (2023)

Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation
por: Waldmann, Victor, et al.
Publicado: (2018)

Massive Accumulation of Myofibroblasts in the Critical Isthmus Is Associated With Ventricular Tachycardia Inducibility in Post-Infarct Swine Heart
por: Dhanjal, Tarvinder S., et al.
Publicado: (2017)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
por: Kharoubi, Mounira, et al.
Publicado: (2021)

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
por: Fischer, Kilian, et al.
Publicado: (2021)

Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature
por: Adam, Robert Daniel, et al.
Publicado: (2021)

Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
por: Aouate, David, et al.
Publicado: (2020)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

High Risk of Sustained Ventricular Arrhythmia Recurrence After Acute Myocarditis
por: Rosier, Laurent, et al.
Publicado: (2020)

Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
por: Gonzalez-Lopez, Esther, et al.
Publicado: (2022)

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
por: Guendouz, Soulef, et al.
Publicado: (2022)

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2023)

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment
por: Oghina, Silvia, et al.
Publicado: (2021)

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
por: Abroud, Hajer, et al.
Publicado: (2022)

Severe bradycardia in critically ill patients with COVID-19 – A cases report
por: Larue, J., et al.
Publicado: (2021)

Comparison and identification of early clinical, biological and echocardiographic prognostic markers in cardiac amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

Transthyretin cardiac amyloidosis in Saudi Arabia and the Middle East: insights, projected prevalence and practical applications
por: Mohty, Dania, et al.
Publicado: (2023)

MitraClip detachment after electrical cardioversion: a case report
por: Yagel, Oren, et al.
Publicado: (2023)

Long-term follow-up of normal and structural heart ventricular tachycardia catheter ablation: real-world experience from a UK tertiary centre
por: Adlan, Ahmed M, et al.
Publicado: (2019)

Left ventricular and atrial function in systemic light chains amyloidosis: an echocardiography and cardiac magnetic resonance comparison
por: Mohty, Dania, et al.
Publicado: (2015)

Posterior longitudinal strain by speckle tracking echocardiography, marker of cardiac amyloidosis?
por: Ternacle, Julien, et al.
Publicado: (2015)

Multiscale study of high energy attosecond pulse interaction with matter and application to proton–Boron fusion
por: Ribeyre, X., et al.
Publicado: (2022)

Electrical cardioversion
por: Sucu, Murat, et al.
Publicado: (2009)

Electrogenic Cardioversion
por: Theodore, Joseph, et al.
Publicado: (2014)

DISCOVERY: a study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis
por: Akinboboye, Olakunle, et al.
Publicado: (2015)

Acute cor pulmonale in Covid-19 related acute respiratory distress syndrome
por: Cavaleiro, Pedro, et al.
Publicado: (2021)

Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy
por: Quarta, C. Cristina, et al.
Publicado: (2022)

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis
por: Galat, Arnault, et al.
Publicado: (2015)

Community-acquired infection caused by the uncommon hypervirulent Klebsiella pneumoniae ST66-K2 lineage
por: Rodrigues, Carla, et al.
Publicado: (2020)

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
por: Ridouani, Fourat, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_315pd6c7gjvrj0lsrlion1hsnf